The links after "Participants" show which SWOG institutions are eligible to participate in this study.
The orange "Where is This Study Open?" tab at the bottom of the page shows the institutions whose Institutional Review Boards (IRBs) have approved the protocol so that it can be opened at that institution. Clicking on the Institution Name will show the points of contact for information about this study at that institution.
SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)
- Phase III Intergroup(Closed)
A Randomized Comparison of 5-FU Infusion and Bolus Cisplatin as an Adjunct to Radiation Therapy, Versus Radiation Therapy Alone in Selected Patients with Stages I-A2, I-B and II-A Carcinoma of the Cervix Following Radical Hysterectomy and Node Dissection
Research Committee: Gynecologic Cancer
Study Coordinator(s): William A. Peters, M.D., William Gordon Jr., M.D., Geoffrey R. Weiss, M.D.